{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:12:53Z","timestamp":1790039573027,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neutropenic enterocolitis (NE) is a severe digestive complication of chemotherapy, primarily affecting patients with acute myeloid leukemia (AML). We hypothesized that NE is linked to intestinal barrier dysfunction and gut dysbiosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Sixty-five AML patients undergoing induction chemotherapy were included in this prospective monocentric cohort. Among them, 26 patients (40%) were diagnosed with NE. Stool samples were subjected to bacterial load quantification (all bacteria quantitative PCR), 16s rRNA metagenomic analysis, and short-chain-fatty-acids quantification. Additionally, fecal calprotectin and human \ud835\udec3-defensin 2 along with plasmatic inflammatory cytokines, and citrulline levels were measured. Human transcriptomic analysis was conducted on samples obtained from anatomical specimens of colectomies of NE patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Gut microbiota underwent significant alterations after chemotherapy, transitioning from a diverse and balanced enterotype to enterotypes exhibiting a reduced \u03b1-diversity, an increased abundance of\n                      <jats:italic>Enterococcus faecalis<\/jats:italic>\n                      , and a decreased abundance of butyrate-producing genera, which correlated with a decreased fecal concentration of butyrate. Simultaneously, post-chemotherapy, plasma citrulline concentrations decreased indicating enterocyte damages. Finally, human transcriptomic analysis found a significant upregulation of the JAK-STAT signaling KEGG pathway in the colons of NE patients encompassing cytokines (IL-6, OSM-OSMR) that play a pivotal role in sustaining local inflammation within the digestive tract.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This work reaffirms the significant influence of chemotherapy on the gut microbiota and the integrity of the enterocyte barrier. Severe NE is marked by the development of a local inflammatory response that may be induced by the reduction in butyrate levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was registered on Clinicaltrials.gov (identifier: NCT04438278).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s40164-025-00661-4","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T08:55:45Z","timestamp":1747385745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses"],"prefix":"10.1186","volume":"14","author":[{"given":"Natacha","family":"Kapandji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Salmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ulmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Kapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Biard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Lengline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me Le","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"1","key":"661_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/SLA.0b013e3181724fe5","volume":"248","author":"BD Badgwell","year":"2008","unstructured":"Badgwell BD, Cormier JN, Wray CJ, Borthakur G, Qiao W, Rolston KV, et al. Challenges in surgical management of abdominal pain in the neutropenic Cancer patient. Ann Surg. 2008;248(1):104\u20139.","journal-title":"Ann Surg"},{"issue":"5","key":"661_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/CCM.0000000000003687","volume":"47","author":"B Duceau","year":"2019","unstructured":"Duceau B, Picard M, Pirracchio R, Wanquet A, P\u00e8ne F, Merceron S, et al. Neutropenic Enterocolitis in critically ill patients: spectrum of the disease and risk of invasive fungal disease. Crit Care Med. 2019;47(5):668\u201376.","journal-title":"Crit Care Med"},{"key":"661_CR3","doi-asserted-by":"publisher","unstructured":"Saillard C, Zafrani L, Darmon M, Bisbal M, Chow-Chine L, Sannini A et al. The prognostic impact of abdominal surgery in cancer patients with neutropenic enterocolitis: a systematic review and meta-analysis, on behalf the Groupe de Recherche en R\u00e9animation Respiratoire du patient d\u2019Onco-H\u00e9matologie (GRRR-OH). Annals of Intensive Care [Internet]. 2018 Dec [cited 2019 Apr 5];8(1). Available from: https:\/\/annalsofintensivecare.springeropen.com\/articles\/https:\/\/doi.org\/10.1186\/s13613-018-0394-6","DOI":"10.1186\/s13613-018-0394-6"},{"issue":"5","key":"661_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/cid\/cis998","volume":"56","author":"L Nesher","year":"2013","unstructured":"Nesher L, Rolston KVI. Neutropenic Enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013;56(5):711\u20137.","journal-title":"Clin Infect Dis"},{"key":"661_CR5","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.blre.2022.100944","volume":"54","author":"N Kapandji","year":"2022","unstructured":"Kapandji N, Azoulay E, Zafrani L. Recent advances in neutropenic Enterocolitis: insights into the role of gut microbiota. Blood Rev. 2022;54:100944.","journal-title":"Blood Rev"},{"issue":"1","key":"661_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/cid\/ciz777","volume":"71","author":"JR Galloway-Pe\u00f1a","year":"2020","unstructured":"Galloway-Pe\u00f1a JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, et al. Gut Microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia. Clin Infect Dis. 2020;71(1):63\u201371.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"661_CR7","doi-asserted-by":"publisher","first-page":"1800897","DOI":"10.1080\/19490976.2020.1800897","volume":"12","author":"T Hueso","year":"2020","unstructured":"Hueso T, Ekpe K, Mayeur C, Gatse A, Joncquel-Chevallier Curt M, Gricourt G, et al. Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening. Gut Microbes. 2020;12(1):1800897.","journal-title":"Gut Microbes"},{"issue":"8","key":"661_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.chom.2023.06.009","volume":"31","author":"N Vallet","year":"2023","unstructured":"Vallet N, Salmona M, Malet-Villemagne J, Bredel M, Bondeelle L, Tournier S, et al. Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses. Cell Host Microbe. 2023;31(8):1386\u2013e14036.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"661_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1.","journal-title":"Nucleic Acids Res"},{"key":"661_CR10","unstructured":"jamovi - open. statistical software for the desktop and cloud [Internet]. [cited 2023 Sep 5]. Available from: https:\/\/www.jamovi.org\/"},{"issue":"11","key":"661_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi C, Renson A, Zohra F, Elsafoury S, Geistlinger L, Kasselman LJ, et al. Reporting guidelines for human Microbiome research: the STORMS checklist. Nat Med. 2021;27(11):1885\u201392.","journal-title":"Nat Med"},{"issue":"1","key":"661_CR12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41597-022-01600-2","volume":"9","author":"A Rashidi","year":"2022","unstructured":"Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Halaweish H, Kaiser T, et al. Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia. Sci Data. 2022;9(1):468.","journal-title":"Sci Data"},{"key":"661_CR13","doi-asserted-by":"publisher","unstructured":"Galloway-Pe\u00f1a JR. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia - Galloway-Pe\u00f1a\u2013\u20092016 - Cancer - Wiley Online Library [Internet]. 2016 [cited 2019 Mar 8]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/https:\/\/doi.org\/10.1002\/cncr.30039","DOI":"10.1002\/cncr.30039"},{"issue":"10","key":"661_CR14","doi-asserted-by":"publisher","first-page":"e0236460","DOI":"10.1371\/journal.pone.0236460","volume":"15","author":"T Rattanathammethee","year":"2020","unstructured":"Rattanathammethee T, Tuitemwong P, Thiennimitr P, Sarichai P, Na Pombejra S, Piriyakhuntorn P, et al. Gut microbiota profiles of treatment-na\u00efve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy. PLoS ONE. 2020;15(10):e0236460.","journal-title":"PLoS ONE"},{"key":"661_CR15","doi-asserted-by":"crossref","unstructured":"Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, Varannes SB des, Massart S et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. alimentary pharmacology & Therapeutics. 2015;42(5):515\u201328.","DOI":"10.1111\/apt.13302"},{"issue":"2","key":"661_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/2050640617737632","volume":"6","author":"KC Fragkos","year":"2018","unstructured":"Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis. United Eur Gastroenterol J. 2018;6(2):181\u201391.","journal-title":"United Eur Gastroenterol J"},{"key":"661_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13054-022-03943-z","volume":"26","author":"S Mu","year":"2022","unstructured":"Mu S, Xiang H, Wang Y, Wei W, Long X, Han Y, et al. The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut. Crit Care. 2022;26:68.","journal-title":"Crit Care"},{"key":"661_CR18","doi-asserted-by":"publisher","unstructured":"Freedberg DE, Zhou MJ, Cohen ME, Annavajhala MK, Khan S, Moscoso DI et al. Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection. Intensive Care Medicine [Internet]. 2018 Jun 23 [cited 2018 Jul 23]; Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00134-018-5268-8","DOI":"10.1007\/s00134-018-5268-8"},{"issue":"1","key":"661_CR19","doi-asserted-by":"publisher","first-page":"e0404222","DOI":"10.1128\/spectrum.04042-22","volume":"11","author":"JJ Giacomini","year":"2023","unstructured":"Giacomini JJ, Torres-Morales J, Dewhirst FE, Borisy GG, Mark Welch JL. Site specialization of human oral Veillonella species. Microbiol Spectr. 2023;11(1):e0404222.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"661_CR20","doi-asserted-by":"publisher","first-page":"9523","DOI":"10.1038\/s41598-017-10034-5","volume":"7","author":"ML Santoru","year":"2017","unstructured":"Santoru ML, Piras C, Murgia A, Palmas V, Camboni T, Liggi S, et al. Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients. Sci Rep. 2017;7(1):9523.","journal-title":"Sci Rep"},{"issue":"1","key":"661_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12866-023-02791-3","volume":"23","author":"MS Mahdy","year":"2023","unstructured":"Mahdy MS, Azmy AF, Dishisha T, Mohamed WR, Ahmed KA, Hassan A, et al. Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity. BMC Microbiol. 2023;23(1):53.","journal-title":"BMC Microbiol"},{"issue":"10","key":"661_CR22","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41564-022-01224-7","volume":"7","author":"DF Rojas-Tapias","year":"2022","unstructured":"Rojas-Tapias DF, Brown EM, Temple ER, Onyekaba MA, Mohamed AMT, Duncan K, et al. Inflammation-associated nitrate facilitates ectopic colonization of oral bacterium Veillonella parvula in the intestine. Nat Microbiol. 2022;7(10):1673\u201385.","journal-title":"Nat Microbiol"},{"issue":"1","key":"661_CR23","doi-asserted-by":"publisher","first-page":"1943288","DOI":"10.1080\/19490976.2021.1943288","volume":"13","author":"R Gacesa","year":"2021","unstructured":"Gacesa R, Vich Vila A, Collij V, Mujagic Z, Kurilshikov A, Voskuil MD, et al. A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease. Gut Microbes. 2021;13(1):1943288.","journal-title":"Gut Microbes"},{"key":"661_CR24","unstructured":"Jones SA. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer."},{"issue":"5","key":"661_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm.4307","volume":"23","author":"NR West","year":"2017","unstructured":"West NR, Hegazy AN, Owens BMJ, Bullers SJ, Linggi B, Buonocore S, et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor\u2013neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017;23(5):579\u201389.","journal-title":"Nat Med"},{"issue":"1","key":"661_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12967-021-02890-7","volume":"19","author":"A \u00d3nody","year":"2021","unstructured":"\u00d3nody A, Veres-Sz\u00e9kely A, Pap D, Rokonay R, Szebeni B, Sziksz E, et al. Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases. J Transl Med. 2021;19(1):237.","journal-title":"J Transl Med"},{"issue":"5","key":"661_CR27","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1172\/JCI121668","volume":"129","author":"L Belarif","year":"2019","unstructured":"Belarif L, Danger R, Kermarrec L, Nerri\u00e8re-Daguin V, Pengam S, Durand T, et al. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease. J Clin Invest. 2019;129(5):1910\u201325.","journal-title":"J Clin Invest"},{"issue":"1","key":"661_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29(1):71\u2013109.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"661_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.4049\/jimmunol.0804169","volume":"183","author":"A Andoh","year":"2009","unstructured":"Andoh A, Shioya M, Nishida A, Bamba S, Tsujikawa T, Kim-Mitsuyama S, et al. Expression of IL-24, an activator of the JAK1\/STAT3\/SOCS3 cascade, is enhanced in inflammatory bowel disease. J Immunol. 2009;183(1):687\u201395.","journal-title":"J Immunol"},{"issue":"7","key":"661_CR30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/ecco-jcc\/jjaa009","volume":"14","author":"MC Barnhoorn","year":"2020","unstructured":"Barnhoorn MC, Hakuno SK, Bruckner RS, Rogler G, Hawinkels LJAC, Scharl M. Stromal cells in the pathogenesis of inflammatory bowel disease. J Crohns Colitis. 2020;14(7):995\u20131009.","journal-title":"J Crohns Colitis"},{"key":"661_CR31","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3389\/fimmu.2019.01093","volume":"10","author":"NR West","year":"2019","unstructured":"West NR. Coordination of Immune-Stroma crosstalk by IL-6 family cytokines. Front Immunol. 2019;10:1093.","journal-title":"Front Immunol"},{"issue":"11","key":"661_CR32","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20061082","volume":"203","author":"MC Kullberg","year":"2006","unstructured":"Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006;203(11):2485\u201394.","journal-title":"J Exp Med"},{"issue":"3","key":"661_CR33","doi-asserted-by":"publisher","first-page":"otz026","DOI":"10.1093\/crocol\/otz026","volume":"360","author":"P Minar","year":"2019","unstructured":"Minar P, Lehn C, Tsai YT, Jackson K, Rosen MJ, Denson LA. Elevated pretreatment plasma Oncostatin M is associated with poor biochemical response to Infliximab. Crohns Colitis. 2019;360(3):otz026.","journal-title":"Crohns Colitis"},{"key":"661_CR34","doi-asserted-by":"crossref","unstructured":"Yoshihiro Yokoyama T, Yamakawa T, Miyake T, Kazama Y, Hayashi D, Hirayama et al. Mucosal gene expression of inflammatory cytokines as biomarkers for predicting treatment response in patients with inflammatory bowel disease [Internet]. 2023 [cited 2023 Sep 19]. Available from: https:\/\/www.researchsquare.com","DOI":"10.21203\/rs.3.rs-2841128\/v1"},{"key":"661_CR35","doi-asserted-by":"publisher","first-page":"8482326","DOI":"10.1155\/2017\/8482326","volume":"2017","author":"V Messina","year":"2017","unstructured":"Messina V, Buccione C, Marotta G, Ziccheddu G, Signore M, Mattia G, et al. Gut mesenchymal stromal cells in immunity. Stem Cells Int. 2017;2017:8482326.","journal-title":"Stem Cells Int"},{"issue":"6418","key":"661_CR36","doi-asserted-by":"publisher","first-page":"eaat9076","DOI":"10.1126\/science.aat9076","volume":"362","author":"Y Litvak","year":"2018","unstructured":"Litvak Y, Byndloss MX, B\u00e4umler AJ. Colonocyte metabolism shapes the gut microbiota. Science. 2018;362(6418):eaat9076.","journal-title":"Science"},{"key":"661_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"Chen G, Ran X, Li B, Li Y, He D, Huang B, et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine. 2018;30:317\u201325.","journal-title":"EBioMedicine"},{"issue":"4","key":"661_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/CS20210778","volume":"136","author":"L Liang","year":"2022","unstructured":"Liang L, Liu L, Zhou W, Yang C, Mai G, Li H, et al. Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the Macrophage\/WNT\/ERK signaling pathway. Clin Sci (Lond). 2022;136(4):291\u2013307.","journal-title":"Clin Sci (Lond)"},{"issue":"9","key":"661_CR39","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, et al. Short-Chain Fatty-Acid-Producing bacteria: key components of the human gut microbiota. Nutrients. 2023;15(9):2211.","journal-title":"Nutrients"},{"issue":"4","key":"661_CR40","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/00365521.2019.1595708","volume":"54","author":"B Tan","year":"2019","unstructured":"Tan B, Luo W, Shen Z, Xiao M, Wu S, Meng X, et al. Roseburia intestinalis inhibits Oncostatin M and maintains tight junction integrity in a murine model of acute experimental colitis. Scand J Gastroenterol. 2019;54(4):432\u201340.","journal-title":"Scand J Gastroenterol"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-025-00661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-025-00661-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-025-00661-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T08:55:50Z","timestamp":1747385750000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-025-00661-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["661"],"URL":"https:\/\/doi.org\/10.1186\/s40164-025-00661-4","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee \u201cComit\u00e9 de Protection des Personnes Ile de France VII\u201d (N\u00b0 ID-RCB: 2019-A02172-55). Patient\u2019s informed consent was waived according to the French law.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patient\u2019s consent was waived according to the French law for histopathological observations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}